2023
The D3 trial is excited to announce that it has successfully completed recruitment in the trial at an exceptional speed. D3 is looking to see if a new tablet, a combination of two anti-HIV medicines,
2023
The PediCAP team is pleased to report that the 1100 patients required for the main trial in this study have now been recruited.
PediCAP is an innovative, EDCTP funded clinical trial,